Literature DB >> 25318804

Hemoperfusion for Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.

Raine Tatara1, Makoto Sato, Shin-ichiro Fujiwara, Iekuni Oh, Kazuo Muroi, Keiya Ozawa, Tadashi Nagai.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH), which is associated with various underlying conditions, is characterized by hypercytokinemia. Because it is frequently lethal, immediate mitigation of the hypercytokinemia is vital to save patients, particularly when treatments for the patient's underlying condition are ineffective on HLH. We herein present a case of Hodgkin lymphoma associated with HLH in which the HLH did not improve even after chemotherapy. We attempted to save the patient using hemoperfusion with a polymyxin B-immobilized fiber column to remove cytokines; following this treatment, the patient rapidly recovered. Hemoperfusion may be a strategic method to rescue intractable HLH patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318804     DOI: 10.2169/internalmedicine.53.2457

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  1 in total

1.  Successful treatment of two cases of classical Hodgkin lymphoma-associated hemophagocytic lymphohistiocyosis with R-CEPP.

Authors:  Patrick J Boland; Livia T Hegerova; Sarah J Williams; Robert W McKenna; Veronika Bachanova; Craig E Eckfeldt
Journal:  Leuk Lymphoma       Date:  2016-06-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.